Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. reports company developments tied to its global natural health and wellness business, including herbal and nutritional supplements, personal care products, and its Synergy Worldwide division. News commonly covers quarterly results, gross margin and volume incentive trends, digital commerce, customer acquisition, auto-ship subscription programs, and performance across markets such as Asia, North America, Europe and Latin America.
Company updates also include executive appointments, supply chain and technology initiatives, and product-level announcements such as Pro-Argi-9+, Synergy’s L-arginine supplement for nitric oxide and circulation support.
Nature's Sunshine Products (Nasdaq: NATR) announced a new scholarship initiative in partnership with the David Eccles School of Business at the University of Utah. The company pledged $200,000 over four years, with the Eccles School matching 50%, totaling $300,000 for full-ride scholarships aimed at diverse, underrepresented students aiming for their first college degree. This effort aligns with the company's commitment to support education, particularly in disadvantaged communities, and stems from their Stronger Together initiative focused on promoting diversity and inclusiveness.
Xenia Hotels & Resorts announced the appointment of Terrence Moorehead to its Board of Directors, effective May 25, 2021. This increases the Board to nine members, with eight being independent. Moorehead, CEO of Nature's Sunshine Products, brings expertise in high-end consumer products and health and wellness, relevant to Xenia's upscale lodging focus. His diverse experience includes executive roles at Avon and other companies. Moorehead expressed enthusiasm about joining Xenia and aims to enhance shareholder value through collaboration with the management team.
Nature's Sunshine (NASDAQ: NATR) is set to launch a new personalization program in North America, allowing practitioners and retailers to offer customized health packs. This initiative is part of the company's digital transformation and strategic roadmap aimed at enhancing business growth. The program is designed to improve customer experience by providing monthly, pre-sorted packs tailored to individual health needs, and has already contributed to record sales over the last three quarters. The service will be free of charge and aims to strengthen the company's relationship with its practitioners.
Nature’s Sunshine Products reported record net sales of $102.4 million for Q1 2021, a 7% increase from the previous year. GAAP net income rose to $4.2 million or $0.20 per diluted share, compared to $3.0 million or $0.15. Non-GAAP net income per diluted share also increased to $0.21. Adjusted EBITDA surged 20% to $11.6 million. Key markets driving growth included Asia and Latin America, while North America faced challenges due to pandemic stockpiling. Operating income slightly improved to 7.5% of net sales, and the company maintained strong cash reserves of $91.3 million.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 6, 2021, at 5:00 p.m. Eastern time to discuss its financial results for Q1 2021, ending March 31, 2021. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Investors can join the call by dialing the provided numbers and are encouraged to register 5-10 minutes before the start. A replay will be accessible following the call through May 20, 2021. For more information, please visit Nature’s Sunshine website.
Nature’s Sunshine Products (Nasdaq: NATR) reported a powerful fourth quarter for 2020, achieving record net sales of $101.7 million, a 11% increase from the previous year. GAAP net income soared 445% to $6.7 million, equivalent to $0.29 per diluted share. The company declared a special cash dividend of $1.00 per share and announced a $15 million share repurchase program. Full-year sales reached $385.2 million, marking a 6% increase from 2019. Despite increased SG&A expenses, the firm continues to prioritize financial stability and future growth initiatives.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on March 10, 2021, at 5:00 p.m. Eastern time to discuss its fourth-quarter and full-year financial results for 2020. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Participants can join the call using the provided toll-free and international dial-in numbers. A replay will be available until March 24, 2021. Nature’s Sunshine operates in over 40 countries, manufacturing high-quality nutritional and personal care products.
Nature’s Sunshine Products (Nasdaq: NATR) announced a record net sales of $100.3 million for the third quarter of 2020, marking a 13% increase from the previous year. GAAP net income rose significantly to $7.2 million or $0.34 per diluted share. Adjusted EBITDA also increased by 13% to $9.4 million.
The growth was fueled by robust consumer demand, new product launches, and easing COVID-19 restrictions in key markets, particularly in U.S. and China. The company aims to further enhance customer engagement and support distributors as part of its business transformation initiatives.
Nature’s Sunshine Products (NASDAQ: NATR) will hold a conference call on November 9, 2020, at 5:00 p.m. Eastern time to discuss its Q3 financial results for the period ending September 30, 2020. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which will include a Q&A session. Participants are encouraged to dial in 5-10 minutes early. The call will be available for replay after 8:00 p.m. Eastern time on the same day, until November 23, 2020.
Nature’s Sunshine operates in over 40 countries, providing high-quality herbal and nutritional products.
On October 16, 2020, qemp, backed by Nature's Sunshine, announced the expansion of its product line with qemp Calm and qemp Joint. These new offerings incorporate whole spectrum hemp extracts designed to support relaxation and joint health. qemp Calm utilizes a unique blend of Sceletium tortuosum and lemongrass for mood improvement, while qemp Joint combines essential oils like Indian frankincense and turmeric for enhanced mobility. Both products focus on activating the endocannabinoid system, ensuring effective results for daily use.